Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-7 of 7 for your search:
Drug:
R-(-)-gossypol acetic acid
Find trials that include:
Any drugs shown
Trial Status:
Closed
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
AT-101-CS-101
, NCT00397293
2.
Safety & Efficacy Study of AT-101 in Combination w/ Rituximab in Previously Untreated Grade I-II Follicular Non-Hodgkin's Lymphoma
Phase:
Phase II
Type:
Treatment
Status:
Completed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
AT-101-CS-203
, NCT00440388
3.
Phase II Study of R-(-)-Gossypol in Patients With Progressive or Recurrent Glioblastoma Multiforme
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
ABTC-0702
, NABTT-0702, 0702, NCT00540722
4.
A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
AT-101-CS-204
, NCT00544960
5.
A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve Metastatic Hormone Refractory Prostate Cancer (HRPC)
Phase:
Phase II
Type:
Treatment
Status:
Closed
Age:
18 and over
Sponsor:
Pharmaceutical / Industry
Protocol IDs:
AT-101-CS-205
, NCT00571675
6.
Phase II Study of R-(-)-Gossypol (AT-101) and Androgen Ablation Therapy in Patients With Newly Diagnosed Metastatic Prostate Cancer
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Temporarily closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
CINJ-080707
, 080707, 8014, CINJ-0220080008, NCT00666666
7.
A Phase I, Open Label Study of AT-101 Plus Radiotherapy and Temozolomide and of AT-101 Plus Adjuvant Temozolomide for Patients with Newly-Diagnosed Glioblastoma Multiforme
Phase:
Phase I
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Closed
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
NABTT-0602
, NCT00390403
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute